Interaction of lactobacillus fermentum BGHI14 with rat colonic mucosa: Implications for colitis induction

Applied and Environmental Microbiology

Volumn 79, Issue 18, 2013, Pages 5735-5744

  Lukic, Jovanka ^a   Strahinic, Ivana ^a   Milenkovic, Marina ^a   Golic, Natasa ^a   Kojic, Milan ^a   Topisirovic, Ljubisa ^a   Begovic, Jelena ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

[No Author keywords available]

Indexed keywords

COLONIC MUCOSA; INTERLEUKIN-1; LACTOBACILLUS FERMENTUM; MUCOSAL BARRIERS; PRO-INFLAMMATORY CYTOKINES; TISSUE REACTIONS; TREATMENT DURATION; TUMOR NECROSIS FACTOR ALPHA;

RATS; TISSUE;

DISEASES;

BACTERIUM; CELL ORGANELLE; DISEASE PREVALENCE; DISEASE TREATMENT; ECOLOGICAL MODELING; FERMENTATION; IMMUNE RESPONSE; RODENT;

CYTOKINE; MESSENGER RNA; TRINITROBENZENESULFONIC ACID;

ANIMAL; ARTICLE; BIOSYNTHESIS; CHEMICALLY INDUCED DISORDER; COLITIS; DISEASE MODEL; GENETICS; HOST PATHOGEN INTERACTION; INTESTINE MUCOSA; LACTOBACILLUS FERMENTUM; MICROBIOLOGY; PHYSIOLOGY; RAT;

ANIMALS; COLITIS; CYTOKINES; DISEASE MODELS, ANIMAL; HOST-PATHOGEN INTERACTIONS; INTESTINAL MUCOSA; LACTOBACILLUS FERMENTUM; RATS; RNA, MESSENGER; TRINITROBENZENESULFONIC ACID;

EID: 84884274497     PISSN: 00992240     EISSN: 10985336     Source Type: Journal    
DOI: 10.1128/AEM.01807-13     Document Type: Article

References (52)

1. Wlodarska M, Willing B, Keeney KM, Menendez A, Bergstrom KS, Gill N, Russell SL, Vallance BA, Finlay BB. 2011. Antibiotic treatment alters the colonic mucus layer and predisposes the host to exacerbated Citrobacter rodentium-induced colitis. Infect. Immun. 79:1536-1545.
2. Hoffmann KM, Deutschmann A, Weitzer C, Joainig M, Zechner E, Högenauer C, Hauer AC. 2010. Antibiotic-associated hemorrhagic colitis caused by cytotoxin-producing Klebsiella oxytoca. Pediatrics 125:e960- e963.
3. Bezkorovainy A. 2001. Probiotics: determinants of survival and growth in the gut. Am. J. Clin. Nutr. 73(Suppl 2):399S- 405S.
4. Rescigno M. 2011. The intestinal epithelial barrier in the control of homeostasis and immunity. Trends Immunol. 32:256-264.
5. Collado MC, Bäuerl C, Pérez-Martínez G. 2012. Defining microbiota for developing new probiotics. Microb. Ecol. Health Dis. 23:18579. http://dx .doi.org/10.3402/mehd.v23i0.18579.
6. Galdeano CM, De Moreno de LeBlank A, Vinderola G, Bibas Bonet ME, Perdigón G. 2007. Proposed model: mechanisms of immunomodulation induced by probiotic bacteria. Clin. Vaccine Immunol. 14:485-492.
7. Corridoni D, Pastorelli L, Mattioli B, Locovei S, Ishikawa D, Arseneau KO, Chieppa M, Cominelli F, Pizarro T. 2012. Probiotic bacteria regulate intestinal epithelial permeability in experimental ileitis by a TNFdependent mechanism. PLoS One 7:e42067. doi:10.1371/journal.pone .0042067.
8. Ardite E, Sans M, Panés J, Romero FJ, Piqué JM, Fernández-Checa JC. 2000. Replenishment of glutathione levels improves mucosal function in experimental acute colitis. Lab. Invest. 80:735-744.
9. Peran L, Camuesco D, Comalada M, Bailon E, Henriksson A, Xaus J, Zarzuelo A, Galvez J. 2007. A comparative study of the preventive effects exerted by three probiotics, Bifidobacterium lactis, Lactobacillus casei and Lactobacillus acidophilus, in the TNBS model of rat colitis. J. Appl. Microbiol. 103:836-844.
10. Khurana I. 2006. Textbook of medical physiology. Elsevier, Noida, India.
11. Geier MS, Butler RN, Giffard PM, Howarth GS. 2007. Lactobacillus fermentum BR11, a potential new probiotic, alleviates symptoms of colitis induced by dextran sulphate sodium (DSS) in rats. Int. J. Food Microbiol. 114:267-274.
12. Yokoyama K, Nakajima N, Ito Y, Iwasaki A, Arakawa Y. 2006. Histoimmunological evaluation for the efficacy of entero nutrient containing n-3 fatty acids in TNBS rat colitis model. J. Clin. Biochem. Nutr. 39:88-97.
13. Zheng L, Gao ZQ, Wang SX. 2000. A chronic ulcerative colitis model in rats. World J. Gastroenterol. 6:150-152.
14. Marjit B. 2009. General anatomy, genetics, histology and embryology, 5th ed. Bimar Kumal Dhur of Academic Publishers, Kolkata, India.
15. Heilig HGHJ, Zoetendal EG, Vaughan EE, Marteau P, Akkermans ADL, de Vos WDL. 2002. Molecular diversity of Lactobacillus spp. and other lactic acid bacteria in the human intestine by specific amplification of 16S ribosomal DNA. Appl. Environ. Microbiol. 68:114-123.
16. Park JW, Crowley DE. 2010. Nested PCR bias: a case study of Pseudomonas spp. in soil microcosms. J. Environ. Monit. 12:985-988.
17. Radojkovic D, Kusic J. 2000. Silver staining of denaturing gradient gel electrophoresis gels. Clin. Chem. 46:883-884.
18. An C, Takahashi H, Kimura B, Kuda T. 2011. Comparison of PCRDGGE and PCR-SSCP analysis for microflora of kaburazushi and daikonzushi, traditional fermented foods made from fish and vegetables. J. Food Technol. 9:1-8.
19. Hanahan D. 1983. Studies on transformation of Escherichia coli with plasmids. J. Mol. Biol. 166:557-580.
20. Dietrich D, Krieger H. 2009. Histological analysis of endocrine disruptive effects in small laboratory fish. John Wiley & Sons, Hoboken, NJ.
21. Roberts RJ, Smail DA, Munro ES. 2012. Laboratory methods, p 439- 481. In Roberts RJ (ed), Fish pathology. Wiley-Blackwell, Hoboken, NJ.
22. Farooq SM, Stillie R, Svensson M, Svanborg C, Strieter RM, Stadnyk AW. 2009. Therapeutic effect of blocking CXCR2 on neutrophil recruitment and dextran sodium sulphate-induced colitis. J. Pharmacol. Exp. Ther. 329:123-129.
23. Chomczynski P, Sacchi N. 2006. The single-step method ofRNAisolation by acid guanidium thiocyanate-phenol chloroform extraction: twentysomething years on. Nat. Protoc. 1:581-585.
24. Cheeseman JF, Winnebeck EC, Millar CD, Kirkland LS, Sleigh J, Goodwin M, Pawley MDM, Bloch G, Lehmann K, Menzel R, Warman GR. 2012. General anesthesia alters time perception by phase shifting the circadian clock. Proc. Natl. Acad. Sci. U. S. A. 109:7061-7066.
25. Ng SC, Hart AL, Kamm MA, Stagg AJ, Knight SC. 2009. Mechanisms of action of probiotics: recent advances. Inflamm. Bowel Dis. 15:300-310.
26. Mañé J, Lorén V, Pedrosa E, Ojanguren I, Xaus J, Cabré E, Doménech E, Gassull MA. 2009. Lactobacillus fermentum CECT 5716 prevents and reverts intestinal damage on TNBS-induced colitis in mice. Inflamm. Bowel Dis. 15:1155-1163.
27. Jiménez E, Langa S, Martín V, Arroyo R, Martín R, Fernández L, Rodríguez JM. 2010. Complete genome sequence of Lactobacillus fermentum CECT 5716, a probiotic strain isolated from human milk. J. Bacteriol. 192:4800.
28. Schlee M, Harder J, Köten B, Stange EF, Wehkamp J, Fellermann K. 2008. Probiotic lactobacilli and VSL#3 induce enterocyte β-defensin 2. Clin. Exp. Immunol. 151:528-535.
29. Kosin B, Rakshit SK. 2006. Microbial and processing criteria for production of probiotics: a review. Food Technol. Biotechnol. 44:371-379.
30. Isolauri E, Sütas Y, Kankaanpää P, Arvilommi H, Salminen S. 2001. Probiotics: effects on immunity. Am. J. Clin. Nutr. 73(Suppl):444S- 450S.
31. Hayashu H, Takahashi R, Nishi T, Sakamoto M, Benno Y. 2005. Molecular analysis of jejunal, ileal, caecal and recto-sigmoidal human colonic microbiota using 16S rRNA gene libraries and terminal restriction fragment length polymorphism. J. Med. Microbiol. 54:1093-1101.
32. Bertazzoni-Minelli E, Benini A, Marzotto M, Sbarbati A, Ruzzenente O, Ferrario R, Hendriks H, Dellaglio F. 2004. Assessment of novel probiotic Lactobacillus casei strains for the production of functional dairy foods. Int. Dairy J. 14:723-736.
33. Boyle RJ, Robins-Browne RM, Tang MLK. 2006. Probiotics use in clinical practice: what are the risks? Am. J. Clin. Nutr. 83:1256-1264.
34. Hoffmann M, Rath E, Hölzwimmer G, Quintanilla-Martinez L, Loach D, Tannock D, Haller D. 2008. Lactobacillus reuteri 100-23 transiently activates intestinal epithelial cells of mice that have a complex microbiota during early stages of colonization. J. Nutr. 138:1684-1691.
35. Galdeano CM, Perdigón G. 2006. The probiotic bacterium Lactobacillus casei induces activation of the gut mucosal immune system through innate immunity. Clin. Vaccine Immunol. 13:219-226.
36. Bekker LG, Moreira AL, Bergtold A, Freeman S, Ryffel B, Kaplan G. 2000. Immunopathologic effects of tumor necrosis factor alpha in murine mycobacterial infection are dose dependent. Infect. Immun. 68:6954- 6961.
37. Onizawa M, Nagaishi T, Kanai T, Nagano K, Oshima S, Nemoto Y, Yoshioka A, Totsuka T, Okamoto R, Nakamura T, Sakamoto N, Tsuchiya K, Aoki K, Ohya K, Yagita H, Watanabe M. 2009. Signaling pathway via TNF-α/NF-kB in intestinal epithelial cells may be directly involved in colitis-associated carcinogenesis. Am. J. Physiol. Gastrointest. Liver Physiol. 296:G850-G859.
38. Sahoo M, Ceballos-Olvera I, del Barrio L, Re F. 2011. Role of inflammasome, IL-1β, and IL-18 in bacterial infections. ScientificWorldJournal 11:2037-2050.
39. Iwakura Y, Ishigame H, Saijo S, Nakae S. 2011. Functional specialization of interleukin-17 family members. Immunity 34:149-162.
40. Zhang Z, Zheng M, Bindas J, Schwarzenberger P, Kolls JK. 2006. Critical role of IL-17 receptor signaling in acute TNBS-induced colitis. Inflamm. Bowel Dis. 12:382-388.
41. Ruyssers NE, De Winter BY, De Man JG, Ruyssers ND, Van Gils AJ, Loukas A, Pearson MS, Weinstock JV, Pelckmans PA, Moreels TG. 2010. Schistosoma mansoni proteins attenuate gastrointestinal motility disturbances during experimental colitis in mice. World J. Gastroenterol. 16:703-712.
42. Daniel C, Poiret S, Goudercourt D, Dennin V, Leyer G, Pot B. 2006. Selecting lactic acid bacteria for their safety and functionality by use of a mouse colitis model. Appl. Environ. Microbiol. 72:5799-5805.
43. Ebach DR, Newberry R, Stenson WF. 2005. Differential role of tumor necrosis factor receptors in TNBS colitis. Inflamm. Bowel Dis. 11:533-540.
44. Guarner F, Malagelada JR. 2003. Role of bacteria in experimental colitis. Best Pract. Res. Clin. Gastroenterol. 17:793-804.
45. Wan YM, Zhu YQ, Xia B, Luo J. 2011. Treating TNBS-induced colitis in rats with probiotics. Turk. J. Gastroenterol. 22:486-493.
46. Barbatis C, Tsopanomichalou M. 2009. Heat shock proteins in inflammatory bowel disease. Ann. Gastroenterol. 22:244-247.
47. Madsen KL. 2012. Enhancement of epithelial barrier function by probiotics. J. Epithel. Biol. Pharmacol. 5(Suppl 1-M8):55-59.
48. Hu S, Wang Y, Lichtenstein L, Tao Y, Musch MW, Jabri B, Antonopoulos D, Claud EC, Chang EB. 2010. Regional differences in colonic mucosa-associated microbiota determine the physiological expression of host heat shock proteins. Am. J. Physiol. Gastrointest. Liver Physiol. 299: G1266-G1275.
49. Konturek PC, Sliwowski Z, Koziel J, Ptak-Belowska A, Burnat G, Brzozowski T, Konturek SJ. 2009. Probiotic bacteria Escherichia coli strain Nissle 1917 attenuates acute gastric lesions induced by stress. J. Physiol. Pharmacol. Suppl. 6:41-48.
50. Mousavi SA, Fønhus MS, Berg T. 2009. Up-regulation of uPARAP/ Endo180 during culture activation of rat hepatic stellate cells and its presence in hepatic stellate cell lines from different species. BMC Cell Biol. 10:39. doi:10.1186/1471-2121-10-39.
51. Tilleux S, Berger J, Hermans E. 2007. Induction of astrogliosis by activated microglia is associated with a down-regulation of metabotropic glutamate receptor 5. J. Neuroimmunol. 189:23-30.
52. Peinnequin A, Mouret C, Birot O, Alonso A, Mathieu J, Clarençon D, Agay D, Chancerelle Y, Multon E. 2004. Rat pro-inflammatory cytokine and cytokine related mRNA quantification by real-time polymerase chain reaction using SYBR green. BMC Immunol. 5:3. doi:10.1186/1471-2172 -5-3.